Form 13G Core Laboratories Inc. /DE/ For: 15 May
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Core Laboratories NV (CLB)
The Core Laboratories share price today is 14.37, view NYSE CLB stock exchange data. Track the latest Core Laboratories share price with real-time updates on CLB stock performance including market cap, day range, 52-week range and dividend yield. Access CLB charts, earnings dates and analyst estimates to support your investment decisions.
14.37
-0.14(-0.93%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.08
14.59
52 wk Range
9.72
20.36
CLB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.0814.59
52 wk Range
9.7220.36
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.28%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.28%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CLB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Neutral
Price Target
16.33
Upside
+13.66%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form 8K Core Laboratories NV For: 29 April
- Investing.com
- Form DEF 14A Core Laboratories NV For: 1 April
- Investing.com
- Form 8K Core Laboratories NV For: 13 May
- Investing.com
- Form 13G Core Laboratories Inc. /DE/ For: 15 May
- Investing.com
- Form 8K Core Laboratories NV For: 13 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
1 Buy
1 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 16.33
(+13.66% Upside)
Core Laboratories NV Earnings Call Summary for Q1/2026
- Q1 2026 EPS of $0.06 missed forecast of $0.26 by 77%; revenue fell 12% sequentially to $121.8M, down 1% year-over-year
- Stock plunged 14.28% to $17.30 after-hours on disappointing results; geopolitical disruptions and severe weather impacted operations
- Net income dropped 72% sequentially to $2.7M; rising raw material and logistics costs pressured margins amid operational challenges
- Company projects EPS recovery to $0.15 in Q3 2026 and $0.20 in Q4 2026; focusing on digital transformation and RAPID platform expansion
- CEO Demshur emphasized navigating geopolitical risks while strengthening diagnostic services; Gulf of Mexico demand remains robust
Last Updated: 30-04-2026, 07:26 pm
Read Full TranscriptEarnings
Latest Release
29-04-2026
EPS / Forecast
0.06 / 0.26
Revenue / Forecast
121.8M / --
Compare CLB to Peers and Sector
Metrics to compare | CLB | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipCLBPeersSector | |
|---|---|---|---|---|
P/E Ratio | 22.7x | 25.4x | 5.8x | |
PEG Ratio | 4.88 | −0.19 | 0.00 | |
Price/Book | 2.4x | 1.5x | 1.1x | |
Price / LTM Sales | 1.3x | 1.3x | 1.5x | |
Upside (Analyst Target) | 9.1% | −3.5% | 20.4% | |
Fair Value Upside | Unlock | 7.6% | 7.5% | Unlock |
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Core Laboratories (CLB) Share Price Today?
The Core Laboratories share price today is 14.37.
What is the current Core Laboratories (CLB) share price and day range?
As of 22-05-2026, the Core Laboratories share price is 14.37, with a previous close of 14.50. The share price has ranged from 14.08 to 14.59 today, while the 52-week range spans from 9.72 to 20.36.
What Is the Core Laboratories Market Cap?
As of today, Core Laboratories market cap is 664.25M.
Does Core Laboratories Pay Dividends? What's The Current Dividend Yield?
The Core Laboratories dividend yield is 0.28%.
What Is the Core Laboratories (CLB) Share Price Target?
The average 12-month share price target for Core Laboratories is 16.33, with a high estimate of 22 and a low estimate of 12. 1 analysts recommend buying, while 1 suggest selling, with an overall rating of Neutral and +13.66% Upside potential.
What Is Core Laboratories's Earnings Per Share (TTM)?
The Core Laboratories EPS (TTM) is 0.62.
When Is the Next Core Laboratories Earnings Date?
Core Laboratories will release its next earnings report on 29-07-2026.
From a Technical Analysis Perspective, Is CLB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
What Stock Exchange Does Core Laboratories Trade On?
Core Laboratories is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Core Laboratories?
The stock symbol for Core Laboratories is "CLB."
How Many Times Has Core Laboratories Stock Split?
Core Laboratories has split 2 times.
How Many Employees Does Core Laboratories Have?
Core Laboratories has 3300 employees.
What Is the CLB Premarket Price?
CLB's last pre-market stock price is 14.70. The pre-market share volume is 20.00, and the stock has changed by 0.20, or 1.38%.
What Is the CLB After Hours Price?
CLB's last after hours stock price is 14.50, the stock has changed by 0.01, or 0.03%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.